https://www.finanznachrichten.de/nachrichten-2025-12/67149543-heron-therapeutics-inc-heron-therapeutics-announces-inclusion-of-aponvie-aprepitant-injectable-emulsion-in-the-newly-released-fifth-consensus-gui-399.htm
APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 ("NK-1") antagonist indicated for the prevention of PONV in...
herontherapeuticsincannouncesaponvie